Synapse
⌘+K
Synapse
PulseExploreClubsResearchersJournals
Instagram
HomeClubsExplore
October 8, 2004The Journal of Urology

Randomized, Double-Blind Placebo Controlled Trial of the Once Daily Antimuscarinic Agent Solifenacin Succinate in Patients With Overactive Bladder

View Full Paper
Ask AI
Bookmark
Share

Authors

LCL. CardozoUniversidade Federal FluminenseMLM. LISECRMR. J. MillardUniversity of Copenhagen

Discussion

Loading...

Member takes

Overview

Key Points

Key points are not available for this paper at this time.

Cite This Study

Cardozo et al. (2004) studied this question.

synapsesocial.com/papers/69dc61fe4264bdb3843591f5https://doi.org/10.1097/01.ju.0000140729.07840.16
View Full Paper
Ask AI
Bookmark
Share

Also Consider

Synapse has enriched 3 closely related papers on similar clinical questions. Consider them for comparative context:

  1. 1Randomized, double‐blind placebo‐ and tolterodine‐controlled trial of the once‐daily antimuscarinic agent solifenacin in patients with symptomatic overactive bladder2004 · 369 citations
  2. 2Urinary Incontinence: Does it Increase Risk for Falls and Fractures?2000 · 557 citations
  3. 3Nocturia: A Risk Factor for Falls in the Elderly1992 · 310 citations